Financial Year |
March 31 2023 |
Monetary Funds |
4,524,450,908.21 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
936,988,627.35 |
Accounts Receivable |
6,311,809,426.31 |
Advances to Suppliers |
496,103,610.52 |
Other Receivables |
184,757,156.91 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
2,657,585,240.54 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
364,522,750.85 |
Total Current Assets |
15,650,253,357.97 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
112,672,854.02 |
Investment Properties |
-- |
Fixed Assetes |
5,150,389,027.77 |
Under-construction Projects |
586,245,859.01 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
858,355,955.74 |
R&D expenses |
-- |
Goodwill |
117,684,578.04 |
Long-Term Deferred and Prepaid Expenses |
31,651,290.85 |
Deferred Income Tax Assets |
313,208,027.73 |
Other Non-Current Assets |
38,657,320.40 |
Sub-Total of Non-Current Assets |
7,241,773,111.65 |
Total Assets |
22,892,026,469.62 |
Short-Term Loans |
10,895,953,523.21 |
Trading Financial liabilities |
-- |
Notes Payable |
452,006,237.25 |
Accounts Payable |
1,006,788,268.50 |
Accounts Received In Advance |
6,853,486.54 |
Employee Compensation Payable |
16,760,156.78 |
Taxes Payable |
43,048,302.10 |
Interest Payable |
-- |
Dividend Payable |
455,481.08 |
Other payables |
968,879,814.86 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
1,305,037,684.60 |
Other Current Liabilities |
325,538,130.90 |
Sub-Total of Current Liabilities |
15,522,431,560.58 |
Long-term Loans |
2,045,560,267.40 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
225,893,556.61 |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
28,274,150.74 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
2,377,405,555.11 |
Total Liabilities |
17,899,837,115.69 |
Paid-In Capital(Or Share Stock) |
1,371,366,248.00 |
Capital Surplus |
1,514,389,571.46 |
Surplus Reserve |
161,642,698.00 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
637,628,323.44 |
Minority Stockholder's Interest |
1,221,183,841.57 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,771,005,512.36 |
Owner's Equity(Stockholder's Equity) |
4,992,189,353.93 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
22,892,026,469.62 |